These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 27382281)

  • 1. A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements.
    Giannakou C; Park MV; de Jong WH; van Loveren H; Vandebriel RJ; Geertsma RE
    Int J Nanomedicine; 2016; 11():2935-52. PubMed ID: 27382281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonclinical regulatory immunotoxicity testing of nanomedicinal products: Proposed strategy and possible pitfalls.
    Giannakou C; Park MVDZ; Bosselaers IEM; de Jong WH; van der Laan JW; van Loveren H; Vandebriel RJ; Geertsma RE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Sep; 12(5):e1633. PubMed ID: 32266791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanomedicinal products: a survey on specific toxicity and side effects.
    Brand W; Noorlander CW; Giannakou C; De Jong WH; Kooi MW; Park MV; Vandebriel RJ; Bosselaers IE; Scholl JH; Geertsma RE
    Int J Nanomedicine; 2017; 12():6107-6129. PubMed ID: 28883724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two guidelines on immunotoxicity testing of medicinal products.
    Dujmović IH
    Arh Hig Rada Toksikol; 2005 Sep; 56(3):265-8. PubMed ID: 16180612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulatory aspects of immunotoxicology.
    Schulte A; Ruehl-Fehlert C
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):385-9. PubMed ID: 16713214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ICH S8 immunotoxicity guidance. Immune function assessment and toxicological pathology: autonomous or synergistic methods to predict immunotoxicity?
    Spanhaak S
    Exp Toxicol Pathol; 2006 Jul; 57(5-6):373-6. PubMed ID: 16723215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotoxicity, genotoxicity and epigenetic toxicity of nanomaterials: New strategies for toxicity testing?
    Dusinska M; Tulinska J; El Yamani N; Kuricova M; Liskova A; Rollerova E; Rundén-Pran E; Smolkova B
    Food Chem Toxicol; 2017 Nov; 109(Pt 1):797-811. PubMed ID: 28847762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the blood compatibility of nanomedicines: A trend analysis of in vitro and in vivo studies.
    Urbán P; Liptrott NJ; Bremer S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 May; 11(3):e1546. PubMed ID: 30556649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Approaches and considerations for the assessment of immunotoxicity for environmental chemicals: a workshop summary.
    Boverhof DR; Ladics G; Luebke B; Botham J; Corsini E; Evans E; Germolec D; Holsapple M; Loveless SE; Lu H; van der Laan JW; White KL; Yang Y
    Regul Toxicol Pharmacol; 2014 Feb; 68(1):96-107. PubMed ID: 24280359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of validation study of assessment of direct immunotoxicity in the rat. The ICICIS Group Investigators. International Collaborative Immunotoxicity Study.
    Toxicology; 1998 Feb; 125(2-3):183-201. PubMed ID: 9570332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The accuracy of extended histopathology to detect immunotoxic chemicals.
    Germolec DR; Kashon M; Nyska A; Kuper CF; Portier C; Kommineni C; Johnson KA; Luster MI
    Toxicol Sci; 2004 Dec; 82(2):504-14. PubMed ID: 15342959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotoxicology: role in the safety assessment of drugs.
    Descotes J
    Drug Saf; 2005; 28(2):127-36. PubMed ID: 15691223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early detection of immunotoxicity: from animal studies to human biomonitoring.
    Van Loveren H; Steerenberg PA; Vos JG
    Toxicol Lett; 1995 May; 77(1-3):73-80. PubMed ID: 7618171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing immunotoxicity: guidelines.
    Putman E; van der Laan JW; van Loveren H
    Fundam Clin Pharmacol; 2003 Oct; 17(5):615-26. PubMed ID: 14703723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From immunotoxicity to nanotherapy: the effects of nanomaterials on the immune system.
    Smith MJ; Brown JM; Zamboni WC; Walker NJ
    Toxicol Sci; 2014 Apr; 138(2):249-55. PubMed ID: 24431216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target organs and systems: methodologies to assess immune system function.
    Karol MH
    Environ Health Perspect; 1998 Apr; 106 Suppl 2(Suppl 2):533-40. PubMed ID: 9599701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines as biomarkers of nanoparticle immunotoxicity.
    Elsabahy M; Wooley KL
    Chem Soc Rev; 2013 Jun; 42(12):5552-76. PubMed ID: 23549679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are pesticides immunotoxic?
    Botham PA
    Adverse Drug React Acute Poisoning Rev; 1990; 9(2):91-101. PubMed ID: 2220474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US FDA "Redbook II" immunotoxicity testing guidelines and research in immunotoxicity evaluations of food chemicals and new food proteins.
    Hinton DM
    Toxicol Pathol; 2000; 28(3):467-78. PubMed ID: 10862567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Summary of a workshop on nonclinical and clinical immunotoxicity assessment of immunomodulatory drugs.
    Piccotti JR; Lebrec HN; Evans E; Herzyk DJ; Hastings KL; Burns-Naas LA; Gourley IS; Wierda D; Kawabata TT
    J Immunotoxicol; 2009 Mar; 6(1):1-10. PubMed ID: 19519157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.